Inmed Pharmaceuticals Inc. is a biopharmaceutical company focused on the development of innovative therapies derived from cannabinoids. The company specializes in advancing its proprietary drug development programs, particularly for conditions related to the central nervous system, as well as other unmet medical needs. By leveraging its expertise in cannabinoid-based technology and precision medicine, Inmed aims to address critical health challenges and improve patient outcomes through its unique formulations and delivery methods.